It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Saving cash on a tight budget is possible with the right strategies. Discover effective tips to stretch your dollars further.
22,187 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Elon Musk’s wealth dipped below $1 trillion as SpaceX valuations cooled, triggering market chatter and a Wisconsin in...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As investors hunt for catalysts in 2026, the idea of a blockbuster stock split from Booking Holdings stands out. This...
In Buffett's final chapters as Berkshire's CEO, one move stood out: selling a stock that helped build his fortune. Th...
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...
A multi-jurisdictional probe led to indictments for 62 people connected to a massive crypto-laundering operation. The...
Costco has delivered outsized gains over the past decade, while Walmart has paced a modern omnichannel comeback. The ...
Trump Media & Technology Group pivots from traditional media toward a Bitcoin treasury, with 2025 revenue of $3.7 mil...